Correlation Between Avenue Therapeutics and Catalyst Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Avenue Therapeutics and Catalyst Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avenue Therapeutics and Catalyst Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avenue Therapeutics and Catalyst Biosciences, you can compare the effects of market volatilities on Avenue Therapeutics and Catalyst Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avenue Therapeutics with a short position of Catalyst Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avenue Therapeutics and Catalyst Biosciences.

Diversification Opportunities for Avenue Therapeutics and Catalyst Biosciences

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Avenue and Catalyst is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Avenue Therapeutics and Catalyst Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Biosciences and Avenue Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avenue Therapeutics are associated (or correlated) with Catalyst Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Biosciences has no effect on the direction of Avenue Therapeutics i.e., Avenue Therapeutics and Catalyst Biosciences go up and down completely randomly.

Pair Corralation between Avenue Therapeutics and Catalyst Biosciences

If you would invest  180.00  in Avenue Therapeutics on October 22, 2024 and sell it today you would earn a total of  5.00  from holding Avenue Therapeutics or generate 2.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy5.26%
ValuesDaily Returns

Avenue Therapeutics  vs.  Catalyst Biosciences

 Performance 
       Timeline  
Avenue Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avenue Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.
Catalyst Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Catalyst Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Catalyst Biosciences is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Avenue Therapeutics and Catalyst Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Avenue Therapeutics and Catalyst Biosciences

The main advantage of trading using opposite Avenue Therapeutics and Catalyst Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avenue Therapeutics position performs unexpectedly, Catalyst Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Biosciences will offset losses from the drop in Catalyst Biosciences' long position.
The idea behind Avenue Therapeutics and Catalyst Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges